Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Halozyme Therapeutics
HALO
5
Ermenegildo Zegna NV
ZGN
US Stock MarketDetailed Quotes
PCRX Pacira BioSciences
- 26.735
- -0.265-0.98%
Trading Apr 30 14:23 ET
1.24BMarket Cap-12.43P/E (TTM)
27.077High26.380Low369.98KVolume26.790Open27.000Pre Close9.89MTurnover0.81%Turnover RatioLossP/E (Static)46.28MShares31.67052wk High1.59P/B1.23BFloat Cap11.16452wk Low--Dividend TTM45.83MShs Float121.950Historical High--Div YieldTTM2.58%Amplitude6.160Historical Low26.733Avg Price1Lot Size
Pacira BioSciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 73.96%484.62M | 73.96%484.62M | 92.96%453.81M | 83.10%404.23M | 87.29%325.89M | -3.49%278.58M | -3.49%278.58M | -28.45%235.19M | -30.22%220.77M | -61.52%174M |
| -Cash and cash equivalents | 80.55%276.77M | 80.55%276.77M | 148.15%245.97M | 184.59%247.05M | 417.80%184.05M | 47.21%153.3M | 47.21%153.3M | -9.42%99.12M | -28.88%86.81M | -84.32%35.55M |
| -Short-term investments | 65.90%207.84M | 65.90%207.84M | 52.75%207.85M | 17.33%157.17M | 2.44%141.84M | -32.10%125.28M | -32.10%125.28M | -37.95%136.07M | -31.07%133.96M | -38.59%138.45M |
| Receivables | 7.34%113.3M | 7.34%113.3M | 3.81%100.65M | 5.75%104.78M | 9.05%101.64M | 7.28%105.56M | 7.28%105.56M | 3.73%96.96M | 8.75%99.08M | 1.20%93.21M |
| -Accounts receivable | 7.34%113.3M | 7.34%113.3M | 3.81%100.65M | 5.75%104.78M | 9.05%101.64M | 7.28%105.56M | 7.28%105.56M | 3.73%96.96M | 8.75%99.08M | 1.20%93.21M |
| Inventory | 20.06%125.28M | 20.06%125.28M | 15.90%111.87M | 12.27%103.44M | 4.09%96.78M | 8.63%104.35M | 8.63%104.35M | -0.29%96.52M | -8.41%92.13M | -10.31%92.98M |
| Other current assets | 1.98%21.93M | 1.98%21.93M | 27.16%23.64M | 13.96%19.77M | 18.01%18.8M | 41.26%21.5M | 41.26%21.5M | 28.96%18.59M | -4.28%17.35M | -16.40%15.93M |
| Total current assets | 46.11%745.13M | 46.11%745.13M | 54.27%689.97M | 47.26%632.21M | 44.40%543.11M | 2.34%509.99M | 2.34%509.99M | -16.15%447.26M | -18.41%429.32M | -43.61%376.11M |
| Non current assets | ||||||||||
| Net PPE | -7.90%216.39M | -7.90%216.39M | -7.73%220.68M | -8.54%225.11M | -7.72%230.43M | -7.64%234.95M | -7.64%234.95M | -9.16%239.18M | -6.54%246.15M | -5.43%249.7M |
| -Gross PPE | -5.65%349.32M | -5.65%349.32M | -5.44%350.41M | -6.68%348.91M | -5.88%350.88M | -0.43%370.25M | -0.43%370.25M | 1.57%370.55M | 4.20%373.9M | 5.09%372.8M |
| -Accumulated depreciation | 1.76%-132.93M | 1.76%-132.93M | 1.25%-129.73M | 3.10%-123.8M | 2.15%-120.45M | -15.17%-135.31M | -15.17%-135.31M | -29.40%-131.37M | -33.81%-127.75M | -35.69%-123.1M |
| Goodwill and other intangible assets | -34.11%425.97M | -34.11%425.97M | -33.37%440.29M | -8.49%617.86M | -8.31%632.18M | -8.14%646.5M | -8.14%646.5M | -10.50%660.82M | -8.94%675.15M | -8.72%689.47M |
| -Goodwill | --0 | --0 | --0 | 0.00%163.24M | 0.00%163.24M | 0.00%163.24M | 0.00%163.24M | 3.74%163.24M | 11.71%163.24M | 12.02%163.24M |
| -Other intangible assets | -11.85%425.97M | -11.85%425.97M | -11.51%440.29M | -11.19%454.61M | -10.89%468.94M | -10.60%483.26M | -10.60%483.26M | -14.36%497.58M | -14.01%511.9M | -13.68%526.22M |
| Investments and advances | --0 | --0 | --36.73M | --36.5M | 341.28%36.54M | -93.52%2.41M | -93.52%2.41M | --0 | --0 | --8.28M |
| Non current deferred assets | -9.77%130.38M | -9.77%130.38M | -11.63%134.02M | -13.45%135.14M | -15.82%141.06M | -9.87%144.49M | -9.87%144.49M | -2.49%151.66M | -6.59%156.14M | -1.01%167.57M |
| Other non current assets | -1.11%35.65M | -1.11%35.65M | ---- | ---- | ---- | 32.68%36.05M | 32.68%36.05M | 34.86%35.55M | -0.52%35.63M | -9.74%32.29M |
| Total non current assets | -24.05%808.39M | -24.05%808.39M | -23.50%831.72M | -8.85%1.01B | -9.33%1.04B | -10.02%1.06B | -10.02%1.06B | -9.47%1.09B | -7.84%1.11B | -6.30%1.15B |
| Total assets | -1.33%1.55B | -1.33%1.55B | -0.83%1.52B | 6.77%1.65B | 3.93%1.58B | -6.35%1.57B | -6.35%1.57B | -11.53%1.53B | -11.05%1.54B | -19.46%1.52B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 21.88%19.13M | 21.88%19.13M | 17.30%19.37M | -22.62%18.73M | -47.96%8.98M | 3.14%15.7M | 3.14%15.7M | 27.67%16.51M | 72.97%24.21M | 9.90%17.26M |
| -accounts payable | 21.88%19.13M | 21.88%19.13M | 17.30%19.37M | -22.62%18.73M | -47.96%8.98M | 3.14%15.7M | 3.14%15.7M | 27.67%16.51M | 73.11%24.21M | 16.29%17.26M |
| Current accrued expenses | 20.56%51.31M | 20.56%51.31M | 27.54%76.38M | 15.28%64.81M | 8.41%66.82M | -33.07%42.56M | -33.07%42.56M | -21.57%59.88M | -27.25%56.22M | -29.70%61.63M |
| Current debt and capital lease obligation | 1,107.79%210.66M | 1,107.79%210.66M | 1,120.07%210.66M | -67.88%9.15M | -10.91%17.64M | -59.22%17.44M | -59.22%17.44M | -59.12%17.27M | -32.03%28.49M | -90.18%19.8M |
| -Current debt | 2,235.10%201.78M | 2,235.10%201.78M | 2,231.51%201.47M | ---- | -20.38%8.64M | -74.32%8.64M | -74.32%8.64M | -74.49%8.64M | -42.25%19.5M | -94.40%10.85M |
| -Current capital lease obligation | 0.98%8.89M | 0.98%8.89M | 6.56%9.19M | 1.87%9.15M | 0.58%9M | -3.51%8.8M | -3.51%8.8M | 3.12%8.63M | 10.41%8.98M | 11.64%8.95M |
| Current liabilities | 218.25%309.92M | 218.25%309.92M | 227.14%306.4M | -14.89%92.69M | -5.32%93.44M | -34.10%97.38M | -34.10%97.38M | -28.79%93.66M | -18.22%108.91M | -67.65%98.7M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -24.69%428.19M | -24.69%428.19M | -24.30%433.77M | 7.97%639.45M | -6.81%564.13M | -21.10%568.6M | -21.10%568.6M | -26.48%573.03M | -24.98%592.23M | -24.28%605.36M |
| -Long term debt | -25.35%383.55M | -25.35%383.55M | -25.21%385.89M | 10.73%589.3M | -5.75%511.69M | -21.66%513.8M | -21.66%513.8M | -27.74%515.94M | -26.28%532.18M | -25.60%542.92M |
| -Long term capital lease obligation | -18.54%44.65M | -18.54%44.65M | -16.14%47.88M | -16.49%50.15M | -16.01%52.45M | -15.43%54.81M | -15.43%54.81M | -12.71%57.09M | -11.14%60.05M | -10.43%62.44M |
| Other non current liabilities | -3.17%37.06M | -3.17%37.06M | -11.81%31.94M | 6.44%35.41M | -34.56%33.58M | 1.27%38.27M | 1.27%38.27M | -32.07%36.22M | -39.21%33.27M | -23.69%51.32M |
| Total non current liabilities | -23.34%465.25M | -23.34%465.25M | -23.56%465.71M | 7.89%674.85M | -8.98%597.72M | -19.98%606.87M | -19.98%606.87M | -26.84%609.25M | -25.90%625.49M | -25.11%656.68M |
| Total liabilities | 10.07%775.17M | 10.07%775.17M | 9.84%772.11M | 4.51%767.54M | -8.50%691.16M | -22.28%704.26M | -22.28%704.26M | -27.10%702.91M | -24.86%734.41M | -36.09%755.38M |
| Shareholders'equity | ||||||||||
| Share capital | 2.17%47K | 2.17%47K | 2.17%47K | 2.17%47K | 2.17%47K | 0.00%46K | 0.00%46K | 0.00%46K | 0.00%46K | 2.22%46K |
| -common stock | 2.17%47K | 2.17%47K | 2.17%47K | 2.17%47K | 2.17%47K | 0.00%46K | 0.00%46K | 0.00%46K | 0.00%46K | 2.22%46K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -93.22%-206.36M | -93.22%-206.36M | -68.91%-222.4M | 44.62%-78.93M | 41.87%-97.82M | 28.20%-106.8M | 28.20%-106.8M | 5.04%-131.67M | -3.31%-142.52M | -6.62%-168.29M |
| Paid-in capital | 3.36%1.01B | 3.36%1.01B | 3.45%996.38M | 3.42%983.18M | 5.70%989.78M | 5.69%976.63M | 5.69%976.63M | 5.91%963.18M | 6.20%950.63M | 7.90%936.42M |
| Less: Treasury stock | --25.12M | --25.12M | --25.12M | --25.12M | ---- | --0 | --0 | ---- | ---- | ---- |
| Gains losses not affecting retained earnings | 38.87%343K | 38.87%343K | 6,880.00%678K | 160.69%105K | 210.95%152K | 165.00%247K | 165.00%247K | 98.51%-10K | 71.40%-173K | 74.00%-137K |
| Total stockholders'equity | -10.55%778.35M | -10.55%778.35M | -9.86%749.58M | 8.82%879.28M | 16.16%892.16M | 12.27%870.13M | 12.27%870.13M | 7.98%831.55M | 6.79%807.98M | 8.24%768.04M |
| Total equity | -10.55%778.35M | -10.55%778.35M | -9.86%749.58M | 8.82%879.28M | 16.16%892.16M | 12.27%870.13M | 12.27%870.13M | 7.98%831.55M | 6.79%807.98M | 8.24%768.04M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
